1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kimco Realty said it entered into an agreement that lets it sell up to $750.0 million of common stock over time through sales agents and forward sale agreements, replacing a September 15, 2023 agreement that was terminated. The Board also approved a new share repurchase program of up to $750 million that replaces the prior program, which gives the company flexibility to issue or buy back shares, though neither is obligated.
Company may issue and sell up to $750.0 million of common stock through sales agents and forward sellers, and is not obligated to sell any shares.
Agent commissions will not exceed 2% of gross sales price of shares sold as sales agent.
Board approved a new repurchase program of up to $750 million that supersedes the prior program; the company is not obligated to buy any particular amount.
Net proceeds are intended for general corporate purposes, including acquisitions, development costs, preferred stock redemptions and reducing debt.
Leidos reported third-quarter fiscal 2025 results with revenue of $4.47 billion, up 7% from a year earlier, and net income of $369 million, or $2.82 per diluted share, up 5%. The company raised its fiscal 2025 non-GAAP diluted EPS guidance to $11.45 to $11.75 from $11.15 to $11.45 and held its revenue guidance at $17.00 to $17.25 billion.
Q3 revenue of $4.47 billion, up 7% year-over-year, including 6% organic growth
Non-GAAP diluted EPS of $3.05, up 4%; GAAP net income margin fell to 8.3% from 8.6%
FY25 non-GAAP diluted EPS guidance raised to $11.45 to $11.75 from $11.15 to $11.45
Quarterly dividend declared at $0.43 per share, up 7.5%, payable December 31, 2025
Innovative Industrial Properties reported third quarter 2025 results, with total revenues of $64.7 million, down 15% from $76.5 million a year earlier, and net income attributable to common stockholders of $28.3 million, or $0.97 per diluted share, versus $1.37 a year earlier. The company attributed the revenue decline mainly to a $14.9 million drop from tenant defaults, and it also disclosed a $270 million commitment to IQHQ and a new $100 million secured revolving credit facility.
Total revenues were $64.7 million versus $76.5 million, a decrease of 15%, driven mainly by a $14.9 million decrease from tenant defaults.
Net income attributable to common stockholders was $28.3 million, or $0.97 per diluted share, compared with $39.7 million, or $1.37, in the third quarter of 2024.
Normalized FFO was $45.2 million, or $1.60 per share, versus $59.5 million, or $2.08, a year earlier.
In October the company closed a three-year, $100 million secured revolving credit facility at one-month SOFR plus 200 basis points, secured by its IQHQ investment.
Cabot reported fiscal fourth-quarter 2025 net sales of $899 million, down from $1,001 million a year earlier, and diluted EPS of $0.79 versus $2.43. For the full fiscal year, adjusted EPS rose 3% to $7.25, but diluted EPS fell to $6.02 from $6.72 and net sales fell to $3.7 billion from $4.0 billion. The company expects fiscal 2026 adjusted EPS of $6.00 to $7.00, citing weak Reinforcement Materials demand and elevated Asian tire imports, which points to a lower range than fiscal 2025.
Q4 fiscal 2025 adjusted EPS was $1.70, down 6% from $1.80; diluted EPS was $0.79 versus $2.43
Full-year fiscal 2025 adjusted EPS was $7.25, up 3% from $7.06, while diluted EPS was $6.02 versus $6.72
Fiscal 2026 adjusted EPS outlook is $6.00 to $7.00; the company cites uncertain macroeconomic and trade conditions and competitive headwinds in Reinforcement Materials
Cabot announced an agreement to acquire Bridgestone Corporation's reinforcing carbons plant in Mexico
On November 2, 2025, Coeur Mining agreed to acquire New Gold through a plan of arrangement, with New Gold shareholders receiving 0.4959 Coeur shares for each New Gold share. The company said the deal implies $8.51 per New Gold share, a 16% premium to New Gold's October 31, 2025 NYSE American close, and a total equity value of about $7 billion. Coeur holders would own about 62% of the combined company and New Gold holders about 38%, so the deal would significantly change Coeur's share count and ownership, and it is subject to shareholder, court and regulatory approvals.
Exchange ratio of 0.4959 Coeur common shares per New Gold common share, implying $8.51 per share based on Coeur's October 31, 2025 NYSE closing price
Total equity value of about $7 billion for New Gold; pro forma combined equity market capitalization of about $20 billion
Coeur stockholders to own about 62% and New Gold shareholders about 38% of the combined company; two New Gold directors, including CEO Patrick Godin, to join Coeur's board
Expected to close in the first half of 2026; outside date May 15, 2026, extendable to August 15, 2026; termination fees of $414 million (Coeur) and $255 million (New Gold) in certain circumstances
On November 2, 2025, SM Energy agreed to merge with Civitas Resources in a deal where each Civitas share converts into 1.45 SM Energy shares. The merger requires approval from both companies' stockholders and regulatory clearances, and SM Energy would increase its authorized shares to 400,000,000 to complete it.
Exchange ratio: each Civitas common share becomes the right to receive 1.45 SM Energy common shares
Combined SM Energy board would have 11 members: six from the current SM Energy board and five from the Civitas board
Termination fees: $85 million payable by Civitas and $79 million payable by SM Energy in specified circumstances; the merger must be completed by August 3, 2026, subject to extension to November 2, 2026 for antitrust clearances
SM Energy authorized shares would rise to 400,000,000; SM Energy stockholders must approve the stock issuance and charter amendment
Insperity reported third-quarter 2025 revenue up 4% to $1.6 billion, but a net loss of $20 million, or $(0.53) per diluted share, compared with net income of $3 million a year earlier, as gross profit fell 15% on higher-than-expected benefits costs. The company also amended its UnitedHealthcare medical coverage arrangement, extending it through 2028 with additional cost savings starting in 2026, and gave its full-year 2025 adjusted EPS guidance of $0.84 to $1.47.
Q3 2025 revenue rose 4% to $1.6 billion; gross profit fell 15% to $195 million
Q3 2025 net loss of $20 million; diluted EPS $(0.53) versus $0.07 in Q3 2024; adjusted EPS $(0.20)
UnitedHealthcare amendment extends the arrangement through 2028 and lets Insperity elect a claim cost limit of $500,000, $750,000, or $1,000,000 per participant per year
Q4 2025 adjusted EPS guidance is $(0.79) to $(0.16); full-year 2025 adjusted EPS guidance is $0.84 to $1.47
JBT Marel reported third quarter 2025 revenue of $1,001.3 million, up from $453.8 million a year earlier, and income from continuing operations of $66.8 million. The company raised its full year 2025 guidance, including revenue of $3,760 million to $3,790 million and adjusted EPS of $6.10 to $6.40, but its GAAP EPS guidance remains a loss of $1.05 to $0.75 per share.
Q3 2025 diluted EPS from continuing operations was $1.28, versus $1.18 in Q3 2024; adjusted EPS was $1.94, versus $1.76.
Full year 2025 guidance: revenue of $3,760 million to $3,790 million and adjusted EBITDA margin of 15.75% to 16.0%.
GAAP EPS guidance for full year 2025 is a loss of $1.05 to $0.75, reflecting a $147 million non-cash pension settlement charge in the first quarter.
The company plans to realign its reporting into two segments in Q4 2025 and expects in-year synergy savings of $40 million to $45 million.
Primoris Services reported third-quarter 2025 revenue of $2,178.4 million, up 32.1% from a year earlier, and net income of $94.6 million, or $1.73 per diluted share, compared with $1.07 a year earlier. The company raised its full-year 2025 net income, EPS and Adjusted EBITDA guidance, and its board declared an $0.08 per share cash dividend payable January 15, 2026.
Q3 2025 revenue $2,178.4 million, up $529.3 million (32.1%), led by the Energy and Utilities segments
Full-year 2025 net income guidance raised to $260.5 million to $271.5 million; diluted EPS guidance raised to $4.75 to $4.95
Full-year 2025 Adjusted EBITDA guidance raised to $510 million to $530 million
Gross profit as a percentage of revenue fell to 10.8% from 12.0% a year earlier
RingCentral reported third quarter 2025 revenue of $639 million, up 5% year over year, and GAAP net income per diluted share of $0.19, compared with a loss of $0.09 a year earlier. The company raised its full-year 2025 free cash flow guidance to $525 million to $530 million and gave fourth quarter revenue guidance of $638 million to $646 million.
Total revenue was $639 million, up 5% from $609 million in Q3 2024; subscriptions revenue rose 6% to $616 million.
GAAP net income per diluted share was $0.19 versus a loss of $0.09; non-GAAP diluted EPS was $1.13 versus $0.95.
Free cash flow was $130 million, up 23% year over year, and full-year 2025 free cash flow guidance was raised to $525 million to $530 million.
The company repurchased $117 million of stock in Q3 and has approximately $384 million remaining under its total authorization.
Unum Group reported third-quarter 2025 net income of $39.7 million ($0.23 per diluted share), down from $645.7 million ($3.46 per diluted share) a year earlier. The decline reflects an after-tax net reserve increase of $377.8 million tied to annual assumption updates, mainly in long-term care. Adjusted operating income fell to $357.1 million ($2.09 per diluted share) from $398.0 million ($2.13), and the company said it expects a comparable $0.10 per share effect in the fourth quarter.
Net income was $39.7 million ($0.23 per diluted share) in Q3 2025, versus $645.7 million ($3.46) in Q3 2024.
After-tax net reserve increase of $377.8 million ($2.21 per diluted share), mainly from long-term care assumption updates.
Adjusted operating income was $357.1 million ($2.09 per diluted share), compared with $398.0 million ($2.13) a year earlier.
Premium income grew 2.9 percent on a constant currency basis; the company returned about $980 million to shareholders year-to-date and will host a call on November 4, 2025 at 8:00 am Eastern Time.
Atlas Energy Solutions reported third quarter 2025 revenue of $259.6 million, down 10.1% from the second quarter, and a net loss of $23.7 million, or $0.19 per share. The company also suspended its quarterly common stock dividend and projected lower Adjusted EBITDA for the fourth quarter, so shareholders face both a lower payout and weaker near-term earnings.
Q3 2025 revenue was $259.6 million, down $29.1 million from Q2 2025; Adjusted EBITDA fell to $40.2 million from $70.5 million.
Net loss was $23.7 million ($0.19 per share), compared with a net loss of $5.6 million in Q2 2025.
The quarterly common stock dividend was suspended; dividend payments were $30.9 million in Q3 2025.
Fourth quarter 2025 Adjusted EBITDA is projected to be lower sequentially, with Sand & Logistics volumes forecast at about 4.8 million tons.
Centerspace reported third-quarter 2025 net income of $3.19 per diluted share, compared with a loss of $0.40 a year earlier, helped by a $79.5 million gain on real estate sales. Core FFO was $1.19 per diluted share, up from $1.18, but the company lowered its 2025 net income per share outlook to $1.97 to $2.19 from $2.50 to $2.76.
Q3 2025 net income of $3.19 per diluted share, versus a $0.40 loss in Q3 2024; results include a $79.5 million gain on sale of real estate.
Q3 2025 Core FFO of $1.19 per diluted share, up 0.8% from $1.18 a year earlier.
2025 net income per diluted share outlook cut to $1.97 to $2.19 from $2.50 to $2.76; Core FFO outlook narrowed to $4.88 to $4.96 from $4.88 to $5.00.
Same-store NOI rose 4.5% in Q3 2025 year over year; total liquidity was $200.4 million at September 30, 2025.
Ormat Technologies reported third-quarter 2025 total revenue of $249.7 million, up 17.9% from a year earlier, and net income attributable to stockholders of $24.1 million, up 9.3%. The company raised its 2025 guidance, now projecting total revenues of $960 million to $980 million and adjusted EBITDA of $575 million to $593 million, which signals higher expected full-year results for shareholders.
Q3 2025 diluted EPS was $0.39, up 8.3% from $0.36; adjusted diluted EPS was $0.41, down from $0.42.
Q3 adjusted EBITDA was $138.4 million, up 0.6%; Product segment revenue rose 66.6% and Energy Storage revenue rose 108.1%.
Product segment backlog was approximately $295 million as of November 3, 2025.
Board declared a quarterly dividend of $0.12 per share, payable December 1, 2025, to holders of record as of November 17, 2025.
Goodyear reported a third-quarter 2025 net loss of $2.2 billion, driven by a $1.4 billion non-cash deferred tax asset valuation allowance and a $674 million non-cash goodwill impairment charge. Excluding significant items, net sales of $4.6 billion, segment operating income of $287 million and adjusted EPS of $0.28 all declined from the prior-year quarter. The company also completed the $650 million sale of its Chemical business on October 31, with about $580 million in cash proceeds that it said will be used to reduce debt.
Q3 2025 net loss of $2.2 billion ($7.62 per share), versus a net loss of $37 million ($0.13 per share) a year earlier
Adjusted EPS of $0.28 versus $0.36 a year earlier; adjusted net income of $82 million versus $102 million
Net sales of $4.6 billion versus $4.8 billion; segment operating income of $287 million versus $346 million
Chemical business sold October 31, 2025 for a $650 million purchase price, with cash proceeds of approximately $580 million
Sherwin-Williams said CFO Allen Mistysyn will retire effective December 31, 2025, and its board elected Benjamin Meisenzahl, the company's current SVP – Finance, as SVP – Finance and CFO effective January 1, 2026. The filing describes a planned succession process, which gives shareholders a known leadership transition timeline rather than an unplanned change.
Allen J. Mistysyn retires as SVP – Finance and CFO effective close of business December 31, 2025, and will take a short-term non-officer role afterward.
Benjamin E. Meisenzahl, 44, has been SVP – Finance since May 2023 and joined the company in January 2004.
Meisenzahl's base salary is $800,000, with a 2026 target annual cash incentive of 100% of salary and a maximum of 200%.
A conference call to discuss the announcement is scheduled for 10:00 a.m. EST on November 4, 2025.
AMERISAFE said its Executive Vice President and Chief Financial Officer, Anastasios Omiridis, will resign effective November 30, 2025, to pursue another opportunity, and that the departure is not due to a disagreement with the company. CEO G. Janelle Frost will assume principal financial and accounting officer duties while the company searches for a new CFO, which matters to shareholders because the finance leadership role will be vacant during the search.
Omiridis notified the company on October 31, 2025; he remains CFO until November 30, 2025.
The resignation is not due to a conflict or disagreement with the company's operations, policies or procedures.
CEO G. Janelle Frost will serve as principal financial officer and principal accounting officer during the CFO search.
The company plans to launch an executive search for a new Executive Vice President and Chief Financial Officer.
Louisiana-Pacific said CEO W. Bradley Southern will retire effective February 19, 2026, and its board appointed President Jason Ringblom to succeed him on the same date. The filing says LP will eliminate the office of President, and no compensation decisions tied to the promotion had been made as of the filing date.
Southern notified the board of his retirement on October 30, 2025, effective February 19, 2026.
Ringblom, who was promoted to President on April 7, 2025, will become CEO effective February 19, 2026.
LP will eliminate the office of President in connection with the promotion.
No compensation determinations related to Ringblom's promotion had been made as of the filing date.
Crescent Energy reported third-quarter 2025 total revenues of $866.6 million, up from $744.9 million a year earlier, and a net loss attributable to the company of $9.5 million, or $0.04 per share, compared with a $9.9 million loss, or $0.07 per share, in the prior-year quarter. The company also improved its 2025 capital outlook by about 4% and is pursuing an approximately $3.1 billion all-stock acquisition of Vital Energy, expected to close in late fourth quarter 2025.
Q3 total revenues were $866.6 million versus $744.9 million; net loss attributable to Crescent was $9.5 million ($0.04 per share) versus $9.9 million ($0.07 per share) a year earlier.
Operating cash flow was $473 million, levered free cash flow $204 million and Adjusted EBITDAX $487 million; Adjusted Net Income was $88 million.
The 2025 capital outlook improved about 4% versus the original outlook, with production maintained when adjusted for divestitures.
Vital Energy acquisition valued at about $3.1 billion, inclusive of net debt; more than $700 million of non-core divestitures signed in September and October 2025.
CNO Financial Group reported third quarter 2025 net income of $23.1 million, or $0.24 per diluted share, up from $9.3 million, or $0.09, a year earlier, and total revenues of $1,188.7 million compared with $1,129.6 million. The results include a $96.7 million non-operating goodwill and other asset impairment tied to the Web Benefits Design and DirectPath acquisitions, and the company raised its run rate operating return on equity target by 50 basis points.
Net income was $23.1 million, or $0.24 per diluted share, versus $9.3 million, or $0.09, in 3Q24.
Net operating income was $127.2 million, or $1.29 per diluted share, versus $119.2 million, or $1.11, in 3Q24.
A $96.7 million non-operating charge covered goodwill and other asset impairment related to the 2019 and 2021 acquisitions of Web Benefits Design and DirectPath.
The operating ROE target was raised by 50 basis points, for 200 basis points of total improvement through 2027 from a 2024 run rate of 10%.
BWX Technologies reported third-quarter 2025 revenue of $866.3 million, up 29% from $672.0 million a year earlier, and GAAP diluted EPS of $0.89, up from $0.76. The company raised its 2025 non-GAAP EPS guidance to $3.75-$3.80 from $3.65-$3.75 and introduced a preliminary 2026 outlook for low-double-digit to low-teens adjusted EBITDA growth, which gives shareholders higher earnings expectations for the year.
Revenue was $866.3 million versus $672.0 million a year earlier; Commercial Operations revenue rose 122% to $251.0 million.
GAAP net income was $82.2 million versus $69.6 million, and non-GAAP EPS was $1.00 versus $0.83.
2025 non-GAAP EPS guidance was raised to $3.75-$3.80 from $3.65-$3.75; adjusted EBITDA guidance was narrowed to about $570 million, the mid-point of the prior range.
Backlog reached $7.4 billion, up 119% year over year, driven by large, multi-year special materials projects.
Tennant reported third quarter 2025 net sales of $303.3 million, down 4.0% from a year earlier, while GAAP net income fell 28.4% to $14.9 million. Adjusted diluted EPS rose 5.0% to $1.46, and the company reaffirmed its full-year net sales and Adjusted EBITDA ranges but now expects organic growth marginally below its prior range, with Adjusted EBITDA toward the low end of $196 million to $209 million.
Q3 net sales of $303.3 million fell 4.0%, with a 5.4% organic decline driven mainly by volume in the Americas.
GAAP diluted EPS was $0.80 versus $1.09, while adjusted diluted EPS was $1.46 versus $1.39.
Adjusted EBITDA rose 4.0% to $49.8 million, and the margin widened 120 basis points to 16.4%.
2025 guidance: net sales $1.210 billion to $1.250 billion reaffirmed; organic growth now projected marginally below the prior (1)% to (4)% range.
Eastman Chemical reported third-quarter 2025 sales of $2.2 billion, down 11% from $2.46 billion a year earlier, and GAAP diluted EPS of $0.40 versus $1.53. The company attributed the decline mainly to lower sales volume, weak consumer demand, and customers reducing tariff-related inventory. It projects full-year 2025 adjusted EPS of $5.40 to $5.65 and operating cash flow approaching $1 billion, which shareholders will weigh against the sharp year-over-year drop in earnings.
Q3 2025 sales were $2,202 million versus $2,464 million in Q3 2024, down 11%; adjusted EBIT was $210 million versus $366 million.
Q3 2025 adjusted diluted EPS was $1.14 versus $2.26 a year earlier; GAAP diluted EPS was $0.40 versus $1.53.
Operating cash flow was $402 million, compared with $396 million in Q3 2024, helped by $204 million of inventory reduction.
Full-year 2025 adjusted diluted EPS is projected at $5.40 to $5.65, and the company expects to reduce costs by more than $75 million net of inflation in 2025.
Sarepta reported third-quarter 2025 total revenues of $399.4 million, down 15% from $467.2 million a year earlier, and a GAAP net loss of $179.9 million, or $1.80 per diluted share, compared with GAAP net income of $33.6 million a year earlier. The filing also disclosed that the ESSENCE confirmatory trial for AMONDYS 45 and VYONDYS 53 did not reach statistical significance on its primary endpoint, and the company plans to meet with the FDA about a path to traditional approval.
Total revenues were $399.4 million versus $467.2 million a year earlier; ELEVIDYS net product revenue fell $49.5 million after shipments to non-ambulatory patients in the U.S. were suspended in June 2025.
GAAP diluted loss per share was $1.80, compared with earnings of $0.34; non-GAAP diluted loss per share was $0.13, compared with earnings of $0.64.
A $138.6 million loss on debt extinguishment and $40.5 million in restructuring charges were recorded in the quarter.
Cash, cash equivalents, restricted cash and investments were $865.2 million at September 30, 2025, down from $1,503.5 million at December 31, 2024.
Ensign Group reported third-quarter 2025 GAAP diluted earnings per share of $1.42, up 6.0% from the prior year, and total revenue of $1.30 billion, up 19.8%. The company raised its full-year 2025 diluted EPS and revenue guidance, which signals higher expected earnings and sales for shareholders.
Q3 GAAP diluted EPS was $1.42 versus $1.34 a year earlier; adjusted diluted EPS was $1.64, up 18.0%
Q3 total revenue was $1.30 billion, up 19.8%; GAAP net income was $83.8 million
2025 diluted EPS guidance raised to $6.48 to $6.54 from $6.34 to $6.46; revenue guidance raised to $5.05 billion to $5.07 billion from $4.99 billion to $5.02 billion
Cash on hand was $443.7 million at September 30, 2025; quarterly dividend of $0.0625 per share was paid
Upwork reported third-quarter 2025 revenue of $201.7 million, up 4% year over year, and net income of $29.3 million, up 6%. The company raised its full-year 2025 revenue and adjusted EBITDA guidance, while its fourth-quarter revenue guidance of $193 million to $198 million is below the third-quarter result.
Q3 2025 revenue of $201.7 million, up 4% year over year; net income of $29.3 million, up 6%
Diluted EPS of $0.21 versus $0.20 in Q3 2024; adjusted EBITDA of $59.6 million, up 38%
Full-year 2025 revenue guidance raised to $782 million to $787 million; adjusted EBITDA guidance raised to $222 million to $225 million
Q4 2025 revenue guidance of $193 million to $198 million; Q4 adjusted EBITDA guidance of $49 million to $52 million
Solaris Energy Infrastructure reported third quarter 2025 revenue of $167 million, up 12% from the second quarter, and net income of $25 million, or $0.31 per diluted share. The company raised its fourth quarter 2025 Total Adjusted EBITDA guidance to $65-70 million from $58-63 million and issued first quarter 2026 guidance of $70-75 million, while its Logistics Solutions segment revenue and EBITDA declined.
Revenue of $167 million rose 12% from the second quarter of 2025; Solaris Power Solutions revenue of $105 million rose 39%.
Net income of $25 million, or $0.31 per diluted share, compared with $0.30 per diluted share in the second quarter of 2025.
Fourth quarter 2025 Total Adjusted EBITDA guidance raised to $65-70 million from $58-63 million; first quarter 2026 guidance set at $70-75 million.
Logistics Solutions revenue fell 16% to $62 million and segment Adjusted EBITDA fell 23% to $17 million.
Apple Hospitality REIT reported third-quarter 2025 net income of $50.9 million, down 9.6% from a year earlier, and EPS of $0.21 versus $0.23. The company lowered its full-year 2025 net income guidance by $5.5 million at the midpoint and cut its RevPAR change outlook by 100 basis points, citing year-to-date performance and the potential effect of economic uncertainty and the government shutdown. Shareholders face lower reported earnings and a weaker hotel revenue outlook, though Adjusted EBITDAre guidance was raised slightly.
Q3 2025 net income was $50.9 million versus $56.3 million in Q3 2024; EPS was $0.21 versus $0.23.
Q3 2025 Adjusted EBITDAre was $122.1 million, down 5.3%; Comparable Hotels RevPAR was $124.01, down 1.8%.
2025 net income guidance is $162 million to $175 million, decreased by $5.5 million at the midpoint; Comparable Hotels RevPAR change guidance is (2.00%) to (1.00%), down 100 bps at the midpoint.
2025 Adjusted EBITDAre guidance is $435 million to $444 million, increased by $0.3 million at the midpoint.
Eagle Bancorp CEO Susan G. Riel told the boards on October 31, 2025 that she intends to retire as President and Chief Executive Officer in 2026, and the board is working with an executive search firm to find a successor. She will step down as board chair effective November 4, 2025, but will remain a director, and James A. Soltesz will become chair. The change is a leadership succession, and no new CEO has been named.
Riel's resignation as board chair takes effect November 4, 2025; she stays on as a director.
James A. Soltesz becomes Chairman and Louis P. "Pete" Mathews Jr. becomes Vice Chairman, both effective November 4, 2025.
Her CEO resignation will take effect on a date mutually agreed with the boards, no later than December 31, 2026.
Clorox reported first-quarter fiscal 2026 net sales of $1.43 billion, down 19%, and diluted EPS of $0.65, down 19% from $0.80. Adjusted EPS fell 54% to $0.85, which the company attributes mainly to lower sales tied to its ERP transition. The company maintained its full-year fiscal 2026 outlook but said current expectations are toward the lower end of the range.
Net sales fell 19% to $1.43 billion, driven mainly by lower shipments related to the ERP transition
Adjusted EPS of $0.85 compared with $1.86 a year earlier; GAAP diluted EPS was $0.65 versus $0.80
Full-year fiscal 2026 net sales still expected to fall 6% to 10%, and diluted EPS between $5.60 and $5.95
Retailer inventory drawdown is expected to reduce fiscal 2026 diluted EPS by about 90 cents
Fastenal's board appointed Max H. Tunnicliff, 47, as Chief Financial Officer and Senior Executive Vice President effective November 10, 2025, ending Sheryl Lisowski's role as interim CFO, which she held since April 17, 2025. Lisowski remains Executive Vice President, Chief Accounting Officer, and Treasurer. A CFO change is a leadership transition that shareholders may watch closely, but the filing reports no change in financial results.
Tunnicliff's base salary is $430,000 per year, with a $225,000 signing bonus in the fourth quarter of 2025.
His bonus for the fourth quarter of 2025 depends on pre-tax income (0.50%) and net income (0.35%) exceeding the prior-year quarter's levels.
He will receive no stock options at appointment, but will be considered for 2026 awards expected to be about $1.2 million in value.
Tunnicliff previously served as CFO of Beko Europe from January 2024 and held senior finance roles at Whirlpool.
Realty Income reported third-quarter 2025 net income available to common stockholders of $315.8 million, or $0.35 per share, up from $261.8 million, or $0.30 per share, a year earlier, on revenue of $1,470.6 million. The company narrowed its 2025 AFFO per share guidance to $4.25 to $4.27 and raised its investment volume guidance to approximately $5.5 billion, but lowered its net income per share guidance to $1.27 to $1.29 from $1.29 to $1.33.
Q3 2025 AFFO was $1.08 per diluted share, compared with $1.05 a year earlier; total revenue was $1,470.6 million, compared with $1,330.9 million.
2025 AFFO per share guidance was revised to $4.25 to $4.27, from $4.24 to $4.28 previously.
2025 net income per share guidance was revised to $1.27 to $1.29, from $1.29 to $1.33 previously.
2025 investment volume guidance was raised to approximately $5.5 billion, from approximately $5.0 billion previously.
Ichor Holdings' CEO Jeffrey Andreson resigned as chief executive and board member effective November 3, 2025, and the company said the resignation was not due to any disagreement over operations, policies, or practices. The board promoted Chief Technology Officer Philip Barros to CEO and a director effective the same day, with a pay package that includes a $700,000 base salary and a 100% target bonus.
Jeffrey Andreson resigned as CEO and director effective November 3, 2025, with his notice given to the board on October 30, 2025.
Philip Barros, CTO since 2015 and SVP of Engineering since 2010, was appointed CEO and a board member effective November 3, 2025.
Barros's offer letter provides a $700,000 annual base salary, a cash bonus targeted at 100% of salary, and restricted and performance restricted stock units each with a $1.75 million grant date fair value.
Ichor reported third quarter 2025 revenue of $239.3 million, up from $211.1 million a year earlier but slightly below $240.3 million in the prior quarter, while its GAAP net loss widened to $22.9 million, or $(0.67) per diluted share. The company guided fourth quarter revenue to $210 million to $230 million, and management said the loss included a $16.7 million inventory impairment tied to a consolidation restructuring plan.
Q3 2025 revenue was $239.3 million, versus $240.3 million in Q2 2025 and $211.1 million in Q3 2024.
GAAP net loss was $22.9 million, or $(0.67) per diluted share, compared with a $9.4 million loss in Q2 2025.
Non-GAAP diluted EPS was $0.07; GAAP gross margin fell to 4.6% from 11.3% in Q2 2025.
Q4 2025 outlook: revenue of $210 million to $230 million (midpoint $220 million) and GAAP diluted EPS of $(0.33) to $(0.17).
ZoomInfo reported third-quarter 2025 revenue of $318.0 million, up 5% from a year earlier, and GAAP net income of $38.7 million, up from $23.8 million. The company raised its full-year 2025 GAAP revenue guidance to $1.237 billion-$1.240 billion from $1.215 billion-$1.225 billion and its adjusted EPS guidance to $1.04-$1.06 from $0.99-$1.01. Unlevered free cash flow fell 14% to $95.3 million, and the company repurchased $86.6 million of its stock during the quarter.
Q3 2025 revenue was $318.0 million, up 5% year-over-year; GAAP operating income was $67.5 million versus $43.5 million a year earlier.
Diluted GAAP EPS was $0.12 versus $0.07; adjusted diluted EPS was $0.28, unchanged from the prior year.
Full-year 2025 GAAP revenue guidance was raised to $1.237-$1.240 billion; Q4 2025 revenue is guided to $307-$310 million.
The company repurchased 8.3 million shares at an average price of $10.46 for $86.6 million in the quarter.
Simon Property Group reported third-quarter 2025 results on November 3, 2025, with net income attributable to common stockholders of $606.2 million, or $1.86 per diluted share, up from $1.46 a year earlier. Real Estate FFO rose 5.6% to $3.22 per diluted share, and the company raised its full-year 2025 Real Estate FFO per share outlook to $12.60 to $12.70. The company also raised its quarterly dividend 4.8% to $2.20 per share and closed its acquisition of the remaining 12% interest in The Taubman Realty Group on October 31, 2025.
Q3 2025 net income attributable to common stockholders was $606.2 million, or $1.86 per diluted share, versus $475.2 million, or $1.46, in Q3 2024.
Q3 2025 Real Estate FFO was $1.215 billion, or $3.22 per diluted share, up 5.6% from $3.05 a year earlier.
2025 Real Estate FFO guidance was increased to $12.60 to $12.70 per diluted share.
Quarterly common dividend raised 4.8% to $2.20 per share, payable December 31, 2025 to holders of record on December 10, 2025.
Sterling Infrastructure reported third quarter 2025 revenue of $689.0 million, up from $593.7 million a year earlier, and net income of $92.1 million, or $2.97 per diluted share, versus $1.97 a year earlier. The company raised its full year 2025 guidance, with diluted EPS now expected at $8.73 to $8.87, and Building Solutions revenue declined 1% in the quarter.
Q3 2025 revenue of $689.0 million versus $593.7 million in Q3 2024; net income of $92.1 million, or $2.97 per diluted share, versus $1.97
Full year 2025 guidance: net income of $270 million to $275 million and diluted EPS of $8.73 to $8.87
Full year 2025 adjusted diluted EPS guidance of $10.35 to $10.52, a non-GAAP measure
Management conference call scheduled for November 4, 2025 at 9:00 a.m. ET
V2X reported third-quarter 2025 revenue of $1.17 billion, up 8% from a year earlier, and net income of $24.6 million, up from $15.1 million. The company raised the midpoints of its 2025 guidance for revenue, adjusted EBITDA, and adjusted diluted EPS, but lowered the midpoint of its adjusted operating cash flow outlook, which it attributed to possible timing delays in collections.
Third-quarter revenue of $1.17 billion, up 8% year over year; diluted EPS of $0.77 versus $0.47 a year earlier
Adjusted diluted EPS of $1.37, up 6% year over year; adjusted EBITDA of $85.2 million
2025 revenue guidance now $4,425 million to $4,500 million, up from $4,375 million to $4,500 million (in millions of dollars)
2025 adjusted operating cash flow guidance lowered to $120 million to $150 million from $150 million to $170 million
Diamondback Energy reported third quarter 2025 net income attributable to the company of $1,018 million, or $3.51 per diluted share, up from $659 million, or $3.19 per share, a year earlier. Total revenues rose to $3,924 million from $2,645 million, and the company raised its full-year 2025 oil production guidance to 495 - 498 MBO/d while narrowing its capital spending range.
Q3 2025 net income attributable to Diamondback was $1,018 million ($3.51 diluted EPS), versus $659 million ($3.19) in Q3 2024.
Total return of capital in Q3 2025 was $892 million, including $603 million of share repurchases and the $1.00 per share base dividend payable November 20, 2025.
Full-year 2025 oil production guidance was raised to 495 - 498 MBO/d; cash capital expenditures were narrowed to $3.45 - $3.55 billion.
Closed divestitures of Environmental Disposal Systems on October 1 ($694 million upfront cash) and EPIC Crude interest on October 31 ($504 million upfront cash).
Viper Energy reported a third quarter 2025 net loss attributable to Viper of $77 million, or $0.52 per Class A share, compared with net income of $49 million in the third quarter of 2024. The loss was driven mainly by a $360 million non-cash impairment, while total operating income rose to $418 million from $211 million a year earlier. The company also agreed to sell its non-Permian assets for $670 million, expected to close in the first quarter of 2026, and declared a total base-plus-variable dividend of $0.58 per share.
Q3 2025 net loss attributable to Viper of $77 million, or $0.52 per Class A share, versus net income of $49 million in Q3 2024
Q3 2025 pro forma cash available for distribution of $165 million, or $0.97 per Class A share
Declared Q3 2025 base dividend of $0.33 and variable dividend of $0.25 per Class A share, payable November 20, 2025
Agreed to sell non-Permian assets for $670 million, with closing expected in Q1 2026
Inspire Medical Systems reported third-quarter 2025 revenue of $224.5 million, up 10%, but net income fell to $9.9 million from $18.5 million, and diluted EPS was $0.34 versus $0.60 a year earlier. The company raised its full-year 2025 diluted EPS guidance to $0.90 to $1.00 from $0.40 to $0.50 while maintaining full-year revenue guidance of $900 million to $910 million.
Q3 revenue was $224.5 million, up 10% from $203.2 million; U.S. revenue was $214.4 million, up 9%.
Net income was $9.9 million versus $18.5 million, and diluted EPS was $0.34 versus $0.60 a year earlier.
Full-year 2025 diluted EPS guidance raised to $0.90 to $1.00 from $0.40 to $0.50; revenue guidance maintained at $900 million to $910 million.
Operating expenses rose 17% to $183.1 million, and cash, cash equivalents and investments were $410.9 million at September 30, 2025.
Tompkins Financial sold its subsidiary Tompkins Insurance Agencies to Arthur J. Gallagher & Co. for about $223 million in cash, subject to customary adjustments, and its press release says the sale closed with a pre-tax gain of $183 million. The same day, the company sold $565.0 million of debt securities at a pre-tax loss of about $79.5 million and reinvested the proceeds at an estimated higher yield, so the net effect on results depends on both moves.
Sale price of about $223 million in cash to Gallagher, announced in an agreement dated October 31, 2025 and closed by November 3, 2025 per the press release.
Press release states a pre-tax gain of $183 million on the sale.
On November 3, 2025, the company sold $565.0 million of debt securities with a 1.56% average book yield, a pre-tax loss of about $79.5 million, and reinvested at an estimated 4.52% average book yield.
Gallagher's post-closing indemnification recourse is capped at $557,500, and the company and its affiliates agreed to a five-year non-compete with limited exceptions.
Pinnacle West reported third-quarter 2025 net income attributable to common shareholders of $413.2 million, or $3.39 per diluted share, up from $3.37 a year earlier, on operating revenues of $1.82 billion. The company raised its 2025 earnings guidance to $4.90-$5.10 per diluted share, citing customer and sales growth and weather, partly offset by higher operations and maintenance expenses, and gave a 2026 range of $4.55-$4.75.
Q3 2025 net income attributable to common shareholders was $413.2 million, or $3.39 per diluted share, versus $395.0 million, or $3.37, in Q3 2024.
Nine-month 2025 diluted EPS was $4.93, compared with $5.32 in the first nine months of 2024, and the company said year-to-date earnings were 2.4% lower.
2025 EPS guidance was raised to $4.90-$5.10; 2026 EPS guidance is $4.55-$4.75 on a weather-normalized basis.
APS plans to invest more than $2.5 billion annually through 2028 and will grant an additional $3 million in shareholder funds for utility bill assistance and related programs.
Adeia reported third-quarter 2025 revenue of $87.3 million, up from $86.1 million a year earlier, and GAAP net income of $8.8 million, down from $19.3 million. The company lowered its full-year 2025 revenue outlook to $360 million-$380 million from $390 million-$430 million, mainly because a license agreement with AMD is now unlikely to close in the fourth quarter, and it filed patent infringement litigation against AMD.
Q3 2025 revenue was $87.3 million versus $86.1 million in Q3 2024; GAAP diluted EPS was $0.08 versus $0.17, and non-GAAP diluted EPS was $0.28 versus $0.27.
Full-year 2025 revenue guidance was cut to $360 million-$380 million from $390 million-$430 million; non-GAAP adjusted EBITDA guidance was cut to $202.3 million-$218.3 million from $232.1 million-$266.1 million.
Adeia filed patent infringement litigation against AMD on November 3, 2025.
The board declared a quarterly dividend of $0.05 per share, payable December 15, 2025, to holders of record on November 24, 2025.
TG Therapeutics reported third quarter 2025 total revenue of $161.7 million, up from $83.9 million a year earlier, and net income of $390.9 million, which includes a non-recurring income tax benefit of approximately $365.0 million. The company raised its full-year 2025 BRIUMVI U.S. net product revenue target to approximately $585 million and its global revenue target to approximately $600 million, and authorized a new $100 million share repurchase program.
Q3 2025 total revenue of $161.7 million, including BRIUMVI U.S. net revenue of $152.9 million, versus $83.9 million total revenue in Q3 2024
Net income of $390.9 million, including a non-recurring income tax benefit of approximately $365.0 million; operating income was $29.4 million
Full-year 2025 BRIUMVI U.S. net product revenue target raised to approximately $585 million from $570-$575 million; global revenue target raised to approximately $600 million from $585 million
Completed the prior $100 million share repurchase, buying about 3.5 million shares at an average $28.55; new $100 million program authorized
Kimberly-Clark agreed to acquire Kenvue in a deal that values Kenvue at an enterprise value of approximately $48.7 billion. Kenvue shareholders would receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share, or $21.01 per share based on the October 31, 2025 closing price. Upon closing, Kimberly-Clark shareholders are expected to own about 54% of the combined company, and the transaction is expected to close in the second half of 2026 subject to shareholder, regulatory and other approvals.
Kenvue shareholders receive $3.50 in cash plus 0.14625 Kimberly-Clark shares per share, a total of $21.01 per share based on the October 31, 2025 closing price
Current Kimberly-Clark shareholders are expected to own about 54% of the combined company; Kenvue shareholders about 46%
Companies expect $2.1 billion in run-rate synergies, net of reinvestment, and the cash component will be funded partly by new debt and the sale of a 51% interest in the IFP business
Expected closing in the second half of 2026; the outside date is November 2, 2026, with a possible extension to May 3, 2027
Bruker reported third-quarter 2025 revenue of $860.5 million, down 0.5% from a year earlier, and a GAAP diluted loss of $(0.41) per share, which included $119.4 million of goodwill and intangible impairment charges and $34.5 million of restructuring charges. Non-GAAP diluted EPS was $0.45, compared with $0.60 a year earlier. The company lowered its FY2025 non-GAAP EPS outlook to $1.85 to $1.90, citing earlier market weakness and EPS dilution from a higher share count.
Q3 2025 revenue $860.5 million, down 0.5% year-over-year and down 4.5% organically
Q3 2025 GAAP diluted loss $(0.41) per share versus EPS of $0.27 a year earlier; non-GAAP diluted EPS $0.45 versus $0.60
FY2025 guidance: revenue $3.41 to $3.44 billion and non-GAAP EPS $1.85 to $1.90
FY2026 cost-savings initiatives of $100 to $120 million are progressing toward the high end of the target
Kontoor Brands reported third quarter 2025 revenue of $853 million, up 27% from a year earlier, and adjusted EPS of $1.44, up 5%. The company raised its full-year 2025 outlook, now expecting adjusted EPS of about $5.50, up from $5.45, and adjusted operating income of about $449 million, up from $443 million.
Q3 revenue was $853 million, up 27%, including a 2-point impact from a shift in shipment timing to the fourth quarter.
Adjusted EPS was $1.44, up 5%; reported diluted EPS was $0.66, versus $1.26 a year earlier.
Full-year 2025 adjusted EPS is now expected at about $5.50 (prior $5.45); adjusted operating income at about $449 million (prior $443 million).
Board declared a regular quarterly dividend of $0.53 per share, payable December 18, 2025.
Pediatrix Medical Group reported third-quarter 2025 net income of $71.7 million, or $0.84 per diluted share, up from $19.4 million, or $0.23, a year earlier. Net revenue fell to $492.9 million from $511.2 million, which the company attributed mainly to practice dispositions. The company raised its full-year 2025 Adjusted EBITDA outlook to a range of $270 million to $290 million.
Q3 2025 net revenue $492.9 million vs. $511.2 million a year earlier; same-unit net revenue grew 8.0 percent
Q3 2025 Adjusted EBITDA $87.3 million vs. $60.2 million; Adjusted EPS $0.67 vs. $0.44
Full-year 2025 Adjusted EBITDA now expected at $270 million to $290 million
Cash and cash equivalents $340.1 million at September 30, 2025; total debt $602 million
Vertiv's subsidiary Vertiv Corporation agreed on October 31, 2025 to acquire Purge Rite Intermediate, LLC (PurgeRite), a provider of fluid management services for data centers, from Milton Street Capital LLC. The deal carries about $1.0 billion in upfront cash, subject to customary adjustments, plus up to $250 million in additional cash tied to post-closing performance metrics, and Vertiv expects to fund it from existing resources. The company says the price is about 10.0x expected 2026 EBITDA including expected cost synergies, and the deal is expected to close in the fourth quarter of 2025.
Upfront cash consideration of about $1.0 billion, plus up to $250 million in additional cash based on performance metrics
Press release says the price is about 10.0x expected 2026 EBITDA including expected cost synergies, and lower if the earn-out is paid
Expected to close in the fourth quarter of 2025; the Hart-Scott-Rodino waiting period must expire or terminate before January 29, 2026
Vertiv expects to fund the acquisition from existing resources; PurgeRite is headquartered in Houston, Texas
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.